nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—TOP2A—uterine cervix—fallopian tube cancer	0.244	0.244	CbGeAlD
Valrubicin—TOP2A—endometrium—fallopian tube cancer	0.221	0.221	CbGeAlD
Valrubicin—TOP2A—uterus—fallopian tube cancer	0.203	0.203	CbGeAlD
Valrubicin—TOP2A—female gonad—fallopian tube cancer	0.166	0.166	CbGeAlD
Valrubicin—TOP2A—vagina—fallopian tube cancer	0.165	0.165	CbGeAlD
